ANDA 76447, held by Teva Pharmaceutical Industries. Fexofenadine Hydrochloride.
As of Nov 22, 2026, ANDA 76447 (Fexofenadine Hydrochloride, Children's Fexofenadine Hydrochloride Allergy, Children's Fexofenadine Hydrochloride Hives), held by Teva Pharmaceutical Industries, was first approved by FDA on Sep 1, 2005, with 8 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 1, 2005 | Original application | Approved |
| Fexofenadine Hydrochloride30MG · tablet;oral | Fexofenadine Hydrochloride | Discontinued |
| Fexofenadine Hydrochloride60MG · tablet;oral | Fexofenadine Hydrochloride | Discontinued |
| Fexofenadine Hydrochloride180MG · tablet;oral | Fexofenadine Hydrochloride | Discontinued |
| Children's Fexofenadine Hydrochloride Allergy30MG · tablet;oral | Fexofenadine Hydrochloride | Discontinued |
| Children's Fexofenadine Hydrochloride Hives30MG · tablet;oral | Fexofenadine Hydrochloride | Discontinued |
| Fexofenadine Hydrochloride Allergy60MG · tablet;oral | Fexofenadine Hydrochloride | Discontinued |
| Fexofenadine Hydrochloride Hives60MG · tablet;oral | Fexofenadine Hydrochloride | Discontinued |
| Fexofenadine Hydrochloride Allergy180MG · tablet;oral | Fexofenadine Hydrochloride | Discontinued |
| Fexofenadine Hydrochloride Hives180MG · tablet;oral | Fexofenadine Hydrochloride | OTC |
| Oct 31, 2019 | Supplement 26Labeling · Standard review | Approved | None posted |
| Sep 4, 2013 | Supplement 17Manufacturing | Approved | None posted |
| Dec 20, 2012 | Supplement 20Labeling | Approved | None posted |
| Apr 13, 2011 | Supplement 18Manufacturing | Approved | None posted |
| Mar 19, 2009 | Supplement 10Labeling | Approved | None posted |
| Dec 31, 2007 | Supplement 7Labeling | Approved | |
| Jan 25, 2007 | Supplement 6Labeling | Approved | None posted |
| Jul 7, 2006 | Supplement 4Labeling | Approved | None posted |
| Sep 1, 2005 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters